நீட்டிக்கப்பட்டது வெளியீடு மாத்திரைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீட்டிக்கப்பட்டது வெளியீடு மாத்திரைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீட்டிக்கப்பட்டது வெளியீடு மாத்திரைகள் Today - Breaking & Trending Today

Acorda Therapeutics Announces Completion of Sale of Manufacturing Operations to Catalent


Posted on
321
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the sale of its manufacturing operations in Chelsea, Massachusetts to Catalent. Under the terms of the agreement, Catalent has paid Acorda $80 million in cash, resulting in expected net proceeds to Acorda of approximately $74 million after transaction fees and expenses and settlement of customary post-closing adjustments. In connection with the sale, Acorda and Catalent have entered into a long-term global supply agreement under which Catalent will manufacture and package INBRIJA for Acorda, ensuring an uninterrupted drug supply for Acorda’s patients and continued adherence to best-in-class manufacturing quality and safety standards. ....

Tierney Saccavino , Exchange Commission , Acorda Therapeutics Inc , Acorda Therapeutics , Extended Release Tablets , பரிமாற்றம் தரகு , அகட சிகிச்சை இன்க் , அகட சிகிச்சை , நீட்டிக்கப்பட்டது வெளியீடு மாத்திரைகள் ,